Sunday - November 24, 2024
Senate Health Committee Chairman Sanders Launches Investigation Into Outrageously High Price of Ozempic, Wegovy in U.S.
April 25, 2024
WASHINGTON, April 25 -- Sen. Bernie Sanders, I-Vermont, chair of the Senate Health, Education, Labor and Pensions Committee, issued the following news release on April 24, 2024:

Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today sent a letter to the CEO of Novo Nordisk, launching an investigation into the outrageously high prices his pharmaceutical company is charging for Ozempic and Wegovy in the United States.
< . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products